Curis
CRIS
#10428
Rank
NZ$25.36 M
Marketcap
NZ$0.65
Share price
-8.61%
Change (1 day)
-84.06%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.28. In 2024 the company made an earnings per share (EPS) of NZ-$12.04 an increase over its 2023 EPS that were of NZ-$15.46.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-46.98%
2024NZ-$12.04-22.15%
2023NZ-$15.46-26.17%
2022NZ-$20.9422.3%
2021NZ-$17.12-25.37%
2020NZ-$22.94-30.93%
2019NZ-$33.22-2.02%
2018NZ-$33.90
2016NZ-$77.05-10%
2015NZ-$85.61138.1%
2014NZ-$35.9640%
2013NZ-$25.68-25%
2012NZ-$34.2566.67%
2011NZ-$20.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.24-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.10-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.36-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.66 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.25 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.41-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA